With the exception of two irofulven resistant cell lines (CAKI1 and ACHN), all other kidney cancer cell lines expressed PTGR1 and a trend could be observed between PTGR1 expression levels and irofulven sensitivity, although the limited number of cell lines did not allow establishing a statistically significant correlation (Supplementary Fig. 1). This evidence concerns the gene PTGR1 and kidney cancer.